EUVIMEDEUVIMED entdecken
Open Access

Differentiation therapy targeting indoleamine 2,3‑dioxygenase 1 in glioblastoma cells in vitro

Kaoru Nishide, Shun Yamamuro, Yumi Aida, Yoshinari Ozawa, Emiko Sano, Atsuo Yoshino

Molecular and Clinical Oncology · 21.07.2026 · 25 (3) · 1-7

DOI: 10.3892/mco.2026.2965 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Clinical Oncology, online erschienen am 21.07.2026. Verfasst von Kaoru Nishide und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, Nihon University School of Medicine, Tokyo 173-8610, Japan. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

3-dioxygenase 1differentiation therapyglioblastomaglioma stem-like cellsin vitroindoleamine 2

Autor:innen und Institutionen

  • Department of Neurological Surgery, Nihon University School of Medicine, Tokyo 173-8610, Japan.

Zitieren

APA

Nishide, K., Yamamuro, S., Aida, Y., Ozawa, Y., Sano, E., & Yoshino, A. (2026). Differentiation therapy targeting indoleamine 2,3‑dioxygenase 1 in glioblastoma cells in vitro. Molecular and Clinical Oncology, 25(3), 1-7. https://doi.org/10.3892/mco.2026.2965

Vancouver

Nishide K, Yamamuro S, Aida Y, Ozawa Y, Sano E, Yoshino A. Differentiation therapy targeting indoleamine 2,3‑dioxygenase 1 in glioblastoma cells in vitro. Molecular and Clinical Oncology. 2026;25(3):1-7. doi:10.3892/mco.2026.2965

BibTeX
@article{Nishide2026,
  author = {Nishide, Kaoru and Yamamuro, Shun and Aida, Yumi and Ozawa, Yoshinari and Sano, Emiko and Yoshino, Atsuo},
  title = {Differentiation therapy targeting indoleamine 2,3‑dioxygenase 1 in glioblastoma cells in vitro},
  journal = {Molecular and Clinical Oncology},
  year = {2026},
  volume = {25},
  number = {3},
  pages = {1--7},
  doi = {10.3892/mco.2026.2965}
}
Kostenlos starten →